CURRENT UNDERSTANDING OF ANTITUMOR IMMUNITY


Cite item

Full Text

Abstract

The review presents analysis of the papers that discuss mechanisms of antitumor immunity. The role of innate and adaptive immune reactions as well as local and systemic is considered in terms of immune defense in clinical and experimental studies. The article discusses characteristics and role tumor-associated antigens for clinical practice. Various types of immune effector cells, including T-cells, NK-cell, DC, tumor associated macrophages, etc., and cytokines, are discussed regarding their contribution into antitumor immune response. The authors also refer to the hypothesis of “immunoediting” and its part in antitumor immunity.

About the authors

I. Zh. Shubina

FSBI «N.N. Blokhin RCRC»

Author for correspondence.
Email: irinashubina@mail.ru
Russian Federation

A. V. Sergeev

FSBI «N.N. Blokhin RCRC»

Russian Federation

L. T. Mamedova

FSBI «N.N. Blokhin RCRC»

Russian Federation

N. Yu. Sokolov

Central Clinical Hospital

Russian Federation

M. V. Kiselevsky

FSBI «N.N. Blokhin RCRC»

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-53039 от  04.03.2013.